249 related articles for article (PubMed ID: 11743646)
1. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan).
Giovanella BC; Stehlin JS; Hinz HR; Kozielski AJ; Harris NJ; Vardeman DM
Int J Oncol; 2002 Jan; 20(1):81-8. PubMed ID: 11743646
[TBL] [Abstract][Full Text] [Related]
2. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
4. Preclinical activity of an i.v. formulation of rubitecan in IDD-P against human solid tumor xenografts.
Sands H; Mishra A; Stoeckler JD; Hollister B; Chen SF
Anticancer Drugs; 2002 Oct; 13(9):965-75. PubMed ID: 12394260
[TBL] [Abstract][Full Text] [Related]
5. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
[TBL] [Abstract][Full Text] [Related]
6. Crystalline camptothecin-20(S)-O-propionate hydrate: a novel anticancer agent with strong activity against 19 human tumor xenografts.
Cao Z; Kozielski A; Liu X; Wang Y; Vardeman D; Giovanella B
Cancer Res; 2009 Jun; 69(11):4742-9. PubMed ID: 19458069
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
[TBL] [Abstract][Full Text] [Related]
8. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
[TBL] [Abstract][Full Text] [Related]
10. Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice.
Ueyama Y
Prog Clin Biol Res; 1987; 229():287-310. PubMed ID: 3601990
[TBL] [Abstract][Full Text] [Related]
11. [Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].
Fujita M; Fujita F; Sakamoto Y; Sugimoto T; Shimozuma K; Taguchi T
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1429-37. PubMed ID: 1854213
[TBL] [Abstract][Full Text] [Related]
12. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.
Boven E; Winograd B; Berger DP; Dumont MP; Braakhuis BJ; Fodstad O; Langdon S; Fiebig HH
Cancer Res; 1992 Nov; 52(21):5940-7. PubMed ID: 1394220
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of HO-221, a derivative of benzoylphenylurea against human cancer xenografts in nude mice].
Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2255-61. PubMed ID: 1929446
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts.
Pantazis P; Kozielski AJ; Vardeman DM; Petry ER; Giovanella BC
Oncol Res; 1993; 5(8):273-81. PubMed ID: 8012059
[TBL] [Abstract][Full Text] [Related]
15. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer.
de Souza PL; Cooper MR; Imondi AR; Myers CE
Clin Cancer Res; 1997 Feb; 3(2):287-94. PubMed ID: 9815685
[TBL] [Abstract][Full Text] [Related]
16. Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.
Giovanella BC; Hinz HR; Kozielski AJ; Stehlin JS; Silber R; Potmesil M
Cancer Res; 1991 Jun; 51(11):3052-5. PubMed ID: 2032244
[TBL] [Abstract][Full Text] [Related]
17. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
18. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the antitumor activity of intraperitoneally and orally administered 5,6-dimethylxanthenone-4-acetic acid by optimal scheduling.
Zhao L; Ching LM; Kestell P; Baguley BC
Clin Cancer Res; 2003 Dec; 9(17):6545-50. PubMed ID: 14695159
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the novel camptothecin gimatecan against orthotopic and metastatic human tumor xenograft models.
De Cesare M; Pratesi G; Veneroni S; Bergottini R; Zunino F
Clin Cancer Res; 2004 Nov; 10(21):7357-64. PubMed ID: 15534112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
